Roger A. Moore

2.3k total citations
50 papers, 1.5k citations indexed

About

Roger A. Moore is a scholar working on Molecular Biology, Neurology and Nutrition and Dietetics. According to data from OpenAlex, Roger A. Moore has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Neurology and 11 papers in Nutrition and Dietetics. Recurrent topics in Roger A. Moore's work include Prion Diseases and Protein Misfolding (22 papers), Neurological diseases and metabolism (11 papers) and Trace Elements in Health (11 papers). Roger A. Moore is often cited by papers focused on Prion Diseases and Protein Misfolding (22 papers), Neurological diseases and metabolism (11 papers) and Trace Elements in Health (11 papers). Roger A. Moore collaborates with scholars based in United States, United Kingdom and South Korea. Roger A. Moore's co-authors include Suzette A. Priola, Richard L. Guerrant, Merle A. Sande, David W. Dorward, Byron Caughey, Philip J. Corr, Andrew G. Hughson, Valerie L. Sim, Ryuichiro Atarashi and Paul Morris and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Roger A. Moore

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger A. Moore United States 24 806 340 310 228 175 50 1.5k
Barry J. Davis United States 28 366 0.5× 187 0.6× 563 1.8× 708 3.1× 615 3.5× 46 3.0k
Kazufumi Yoshihara Japan 20 815 1.0× 116 0.3× 79 0.3× 107 0.5× 244 1.4× 46 1.9k
Henry L. Schreiber United States 15 1.2k 1.5× 116 0.3× 105 0.3× 217 1.0× 69 0.4× 33 2.4k
Xiaofei Yu China 16 2.1k 2.6× 82 0.2× 157 0.5× 349 1.5× 75 0.4× 39 4.2k
A. A. Miles United Kingdom 26 502 0.6× 46 0.1× 140 0.5× 141 0.6× 125 0.7× 82 2.4k
Sophie Leclercq Belgium 26 1.9k 2.4× 200 0.6× 258 0.8× 298 1.3× 44 0.3× 54 3.4k
Rasha Hammamieh United States 29 1.2k 1.4× 89 0.3× 119 0.4× 248 1.1× 99 0.6× 147 2.8k
Yajing Chen China 19 486 0.6× 93 0.3× 35 0.1× 108 0.5× 88 0.5× 51 1.7k
Sofia Eriksson United Kingdom 27 582 0.7× 58 0.2× 90 0.3× 220 1.0× 453 2.6× 65 2.9k
Marianne V. Chew Canada 20 2.2k 2.7× 198 0.6× 190 0.6× 257 1.1× 93 0.5× 30 3.9k

Countries citing papers authored by Roger A. Moore

Since Specialization
Citations

This map shows the geographic impact of Roger A. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger A. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger A. Moore more than expected).

Fields of papers citing papers by Roger A. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger A. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger A. Moore. The network helps show where Roger A. Moore may publish in the future.

Co-authorship network of co-authors of Roger A. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Roger A. Moore. A scholar is included among the top collaborators of Roger A. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger A. Moore. Roger A. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Kyung‐Je, et al.. (2023). Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity. Biochemistry and Biophysics Reports. 34. 101446–101446. 4 indexed citations
2.
3.
Faris, Robert, Roger A. Moore, Anne Ward, et al.. (2017). Cellular prion protein is present in mitochondria of healthy mice. Scientific Reports. 7(1). 41556–41556. 33 indexed citations
4.
Moore, Roger A., Robert Faris, & Suzette A. Priola. (2015). Proteomics applications in prion biology and structure. Expert Review of Proteomics. 12(2). 171–184. 8 indexed citations
5.
Moore, Roger A., Daire O’Shea, Tony Geoghegan, Patrick Mallon, & Gerard Sheehan. (2013). Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe. Infection. 41(3). 681–686. 69 indexed citations
6.
Timmes, Andrew, Roger A. Moore, Elizabeth R. Fischer, & Suzette A. Priola. (2013). Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity. PLoS ONE. 8(7). e71081–e71081. 36 indexed citations
7.
Corr, Philip J., Marcus R. Munafò, Roger A. Moore, & Veena Kumari. (2013). Applying neuroscience to mental disorder. Psychologist. 26(1). 26–29.
8.
Moore, Roger A., et al.. (2012). Behavioural Inhibition System (BIS) sensitivity differentiates EEG theta responses during goal conflict in a continuous monitoring task. International Journal of Psychophysiology. 85(2). 135–144. 25 indexed citations
9.
Moore, Roger A.. (2011). Separate Anesthesia Consent: PRO: It Is Way Past Time for a Separate Anesthesia Informed Consent Document. ASA Newsletter. 75(7). 50–54. 1 indexed citations
10.
Moore, Roger A., Andrew Timmes, Phillip A. Wilmarth, David Safronetz, & Suzette A. Priola. (2011). Identification and removal of proteins that co‐purify with infectious prion protein improves the analysis of its secondary structure. PROTEOMICS. 11(19). 3853–3865. 16 indexed citations
11.
Tribouillard‐Tanvier, Déborah, James A. Carroll, Roger A. Moore, James F. Striebel, & Bruce Chesebro. (2011). Role of Cyclophilin A from Brains of Prion-infected Mice in Stimulation of Cytokine Release by Microglia and Astroglia in Vitro. Journal of Biological Chemistry. 287(7). 4628–4639. 21 indexed citations
12.
Moore, Roger A., Lara M. Taubner, & Suzette A. Priola. (2009). Prion protein misfolding and disease. Current Opinion in Structural Biology. 19(1). 14–22. 61 indexed citations
13.
Lee, Kil Sun, Lynne D. Raymond, Gregory J. Raymond, et al.. (2007). Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein. Journal of Biological Chemistry. 282(50). 36525–36533. 40 indexed citations
14.
Atarashi, Ryuichiro, Roger A. Moore, Valerie L. Sim, et al.. (2007). Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nature Methods. 4(8). 645–650. 264 indexed citations
15.
Kocisko, David A., et al.. (2006). Identification of prion inhibitors by a fluorescence-polarization-based competitive binding assay. Analytical Biochemistry. 363(1). 154–156. 9 indexed citations
16.
Moore, Roger A., Ina Vorberg, & Suzette A. Priola. (2006). Species barriers in prion diseases — brief review. PubMed. 187–202. 61 indexed citations
17.
Moore, Roger A., Christian Herzog, John S. Errett, et al.. (2006). Octapeptide repeat insertions increase the rate of protease‐resistant prion protein formation. Protein Science. 15(3). 609–619. 55 indexed citations
18.
Moore, Roger A., et al.. (2005). Theta phase locking across the neocortex reflects cortico-hippocampal recursive communication during goal conflict resolution. International Journal of Psychophysiology. 60(3). 260–273. 43 indexed citations
19.
Benfield, David A., et al.. (1988). Combined rotavirus and K99 Escherichia coli infection in gnotobiotic pigs. American Journal of Veterinary Research. 49(3). 330–337. 16 indexed citations
20.
Finch, L, Peter E. Hicks, & Roger A. Moore. (1977). The effects of indapamide on Vascular reactivity in experimental hypertension. Current Medical Research and Opinion. 5(sup1). 44–54. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry J. Davis Breakdown of academic impact, for papers by Kazufumi Yoshihara Breakdown of academic impact, for papers by Henry L. Schreiber Breakdown of academic impact, for papers by Xiaofei Yu Breakdown of academic impact, for papers by A. A. Miles Breakdown of academic impact, for papers by Sophie Leclercq Breakdown of academic impact, for papers by Rasha Hammamieh Breakdown of academic impact, for papers by Yajing Chen Breakdown of academic impact, for papers by Sofia Eriksson Breakdown of academic impact, for papers by Marianne V. Chew
Rankless by CCL
2026